Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
CardioVascular and Interventional Radiology
Published in: CardioVascular and Interventional Radiology 7/2017

01-07-2017 | Technical Note

Treatment of Type II Endoleaks with a Novel Agent: Precipitating Hydrophobic Injectable Liquid (PHIL)

Authors: Amir Helmy, Nadeem Shaida

Published in: CardioVascular and Interventional Radiology | Issue 7/2017

Login to get access

Abstract

Objective

Endovascular aortic aneurysm repair has become the principle technique used to treat abdominal aortic aneurysms. However, its long-term success is limited by complications, including type II endoleaks from lumbar arteries and the inferior mesenteric artery. Treatment of these endoleaks can be difficult. The most commonly performed procedure is embolisation via mesenteric or iliolumbar vessels. Embolic agents currently used include coils, glue and Onyx, all of which have their limitations. Our aim was to assess a novel embolic agent precipitating hydrophobic injectable liquid (PHIL) this is currently used in the treatment by neuro-interventionists in the treatment of cerebral arterio-venous malformations.

Methods

Here we describe three patients successfully treated with PHIL.

Results

All three patients had type II endoleaks which were successfully embolised. PHIL displayed favourable embolic characteristics with good distal penetration, rapid injection speed and a lack of glare artefact on follow-up CT.

Conclusion

PHIL is a promising novel embolic agent in the treatment of type II endoleaks, our initial experience has been positive but larger series will be required to evaluate this further.
Literature
1.
Chaikof EL, Brewster DC, Dalman RL, et al. SVS practice guidelines for the care of patients with an abdominal aortic aneurysm: executive summary. J Vasc Surg. 2009;50:880–96.CrossRefPubMed
2.
Aziz A, Menias CO, Sanchez LA, et al. Outcomes of percutaneous endovascular intervention for type II endoleak with aneurysm expansion. J Vasc Surg. 2012;55:1263–7.CrossRefPubMed
3.
van Marrewijk CJ, Fransen G, Laheij RJ, et al. EUROSTAR Collaborators. Is a type II endoleak after EVAR a harbinger of risk? causes and outcome of open conversion and aneurysm rupture during follow-up. Eur J Vasc Endovasc Surg. 2004;27:128–37.CrossRefPubMed
4.
Cho JS, Park T, Kim JY, et al. Prior endovascular abdominal aortic aneurysm repair provides no survival benefits when the aneurysm ruptures. J Vasc Surg. 2010;52:1127–34.CrossRefPubMed
5.
Jones JE, Atkins MD, Brewster DC, et al. Persistent type 2 endoleak after endovascular repair of abdominal aortic aneurysm is associated with adverse late outcomes. J Vasc Surg. 2007;46:1–8.CrossRefPubMed
6.
Abularrage CJ, Crawford RS, Conrad MF, et al. Preoperative anatomic variables are predictive of persistent type 2 endoleak after EVAR. J Vasc Surg. 2010;52:19–24.CrossRefPubMed
7.
Kasirajan K, Matteson B, Marek JM, Langsfeld M. Technique and results of transfemoral super selective coil embolization of type II lumbar endoleak. J Vasc Surg. 2003;38:61–6.CrossRefPubMed
8.
Rial R, Serrano F, Vega M, et al. Treatment of type II endoleaks after endovascular repair of abdominal aortic aneurysms: translumbar puncture and injection of thrombin into the aneurysm sac. Eur J Vasc Endovasc Surg. 2004;27:333–5.CrossRefPubMed
9.
Wisselink W, Cuesta MA, Berends FJ, et al. Retroperitoneal endoscopic ligation of lumbar and inferior mesenteric arteries as a treatment of persistent endoleak after endoluminal aortic aneurysm repair. J Vasc Surg. 2000;31:1240–4.CrossRefPubMed
10.
Hinchliffe RJ, Singh-Ranger R, Whitaker SC, Hopkinson BR. Type II endoleak: transperitoneal sacotomy and ligation of side branch endoleaks responsible for aneurysm sac expansion. J Endovasc Ther. 2002;9:539–42.CrossRefPubMed
11.
Faries PL, Cadot H, Agarwal G, et al. Management of endoleak after endovascular aneurysm repair: cuffs, coils, and conversion. J Vasc Surg. 2003;37:1155–61.CrossRefPubMed
12.
Sheehan MK, Barbato J, Compton CN, et al. Effectiveness of coiling in the treatment of endoleaks after endovascular repair. J Vasc Surg. 2004;40:430–4.CrossRefPubMed
13.
Görich J, Rillinger N, Sokiranski R, et al. Embolization of type II endoleaks fed by the inferior mesenteric artery: using the superior mesenteric artery approach. J Endovasc Ther. 2000;7:297–301.CrossRefPubMed
14.
Naveed U. SaqiB, KriStofer M, CharltoN, Ali Azizzadeh Managing type II endoleaks. Endovasc Today. 2013;1:45–50.
15.
Samaniego E, Kalousek V, Abdo G, Ortega-Gutierrez S J. Preliminary experience with Precipitating Hydrophobic Injectable Liquid (PHIL) in treating cerebral AVMs. Neurointerv Surg 2016;8:1253–1255.CrossRef
16.
Leyon JJ, Chavda S, Thomas A, Lamin S. Preliminary experience with the liquid embolic material agent PHIL (precipitating hydrophobic injectable liquid) in treating cranial and spinal dural arteriovenous fistulas: technical note. J Neurointerv Surg. 2016;8:596–602.CrossRefPubMed
17.
Karthikesalingam A, Thrumurthy SG, Jackson D, et al. Current evidence is insufficient to define an optimal threshold for intervention in isolated type II endoleak after endovascular aneurysm repair. J Endovasc Ther. 2012;19:200–8.CrossRefPubMed
18.
Smith SJ, Thomas A, Ashpole RD. Intra-operative combustion of Onyx embolic material. Br J Neurosurg. 2009;23(1):76–8.CrossRefPubMed
Metadata
Title
Treatment of Type II Endoleaks with a Novel Agent: Precipitating Hydrophobic Injectable Liquid (PHIL)
Authors
Amir Helmy
Nadeem Shaida
Publication date
01-07-2017
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 7/2017
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-017-1603-7

Other articles of this Issue 7/2017

CardioVascular and Interventional Radiology 7/2017 Go to the issue

Technical Note

A Novel External Carotid Arterial Sheath System for Intra-arterial Infusion Chemotherapy of Head and Neck Cancer

Laboratory Investigation

Protective and Heat Retention Effects of Thermo-sensitive Basement Membrane Extract (Matrigel) in Hepatic Radiofrequency Ablation in an Experimental Animal Study

Clinical Investigation

Safety and Efficacy of Sodium Tetradecyl Sulfate and Lipiodol Foam in Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Large Porto-Systemic Shunts

Clinical Investigation

Effectiveness of the Conservative Therapy for Symptomatic Isolated Celiac Artery Dissection

Clinical Investigation

A Survey of Pulmonary Arteriovenous Malformation Screening, Management, and Follow-Up in Hereditary Hemorrhagic Telangiectasia Centers of Excellence

Case Report

Accessory Splenic Artery: A Rare Cause of Upper Gastrointestinal Bleeding